Changes in metabolic parameters in psoriasis patients treated with interleukin-12/23 blockade (ustekinumab)
Background: The associations between psoriasis, metabolic syndrome, and cardiovascular events are increasingly recognized. Studies have shown decreased cardiovascular events with the treatment of methotrexate and anti-tumor necrosis factor-α. However, effects of interleukin (IL)-12/23 blockade remai...
Shranjeno v:
Main Authors: | , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |